GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities

GlaxoSmithKline advances multi-city discussion focused on improving the health
                              of US communities

- "A Conversation on Community Health" Comes to St. Louis to Address Health
Barriers and Explore Innovative Solutions

PR Newswire

ST. LOUIS, Dec. 12, 2012

ST. LOUIS, Dec.12, 2012 /PRNewswire/ --GlaxoSmithKline plc (LSE/NYSE: GSK)
today proceeded with the next city stop in its national initiative to examine
the barriers and identify opportunities to build healthier communities in the
United States. The program, "A Conversation on Community Health" – which
kicked off in Philadelphia in September – is taking place today in St. Louis
as the second of three events The Atlantic is hosting in U.S. cities to
explore what it means, and what it takes, to be a healthy community.

GSK is underwriting the events to uncover innovative and community-based
collaborations with health organizations, public officials, advocates and
citizens that will guide a new approach to improving health at the local
level. Insights gained through the series of local discussions will help shape
the future strategic direction for GSK's community programs and local
engagement in the U.S.

"At GSK, we're always asking ourselves what we can do to be a better partner
in the communities in which we serve patients to ensure that they have the
resources and opportunities they need to live healthier lives," said Deirdre
Connelly, President, North America Pharmaceuticals at GlaxoSmithKline. "While
there are many innovative and effective local community programs doing great
work across St. Louis, and in other cities across the United States, we
believe it's possible to work together even more effectively to drive greater
collective impact. It is urgent that organizations collaborate to uncover new
ideas, and rethink incentives for improving the overall health of the
community as a whole."

In St. Louis, The Atlantic will convene an expert working summit of some of
the region's top minds in the fields of medicine, public health, academia,
government, business and philanthropy to analyze the broader factors that
influence health. The group will also share examples of approaches across the
city that are effectively overcoming systemic barriers to better outcomes.

A town hall meeting immediately following the working summit will feature a
keynote interview with Jackie Joyner-Kersee, Olympic legend and East St. Louis
native addressing the work her foundation is doing to improve the health in
the community. A panel discussion will include prominent speakers, such as
Robert Fruend, Jr., Chief Executive Officer, St. Louis Regional Health
Commission; Melba Moore, MS, CPHA, Commissioner of Health for the City of St.
Louis Department of Health; Dr. Jason Purnell, Assistant Professor at the
Brown School of Social Work and Institute for Public Health at Washington
University; and Joy Krieger, Executive Director, Asthma and Allergy Foundation
of America, St. Louis Chapter.

"St. Louis is committed to being a healthy community for all ages," said
Pamela Rice Walker, MPA, CPHA, St. Louis City Health Director. "We have seen
substantial reductions in lead poisoning, infant mortality, and asthma
hospitalizations among our children over the past 10 years. However, we need
to remain vigilant and creative in our approaches to reducing obesity and
diabetes among our youth."

The United States spends more per capita on health care than any other nation,
but there are large disparities in health outcomes in relation to race,
community of residence, and individual and community socioeconomic factors.^1

St. Louis, where GSK has manufacturing operations, is a natural choice for the
second stop in this multi-city program aimed at understanding community health
challenges. Despite overall improvement in health status throughout the St.
Louis region over the past 10 years, race- and gender-based disparities
persist. Three-fold differences or greater are observed between
African-Americans and Caucasians in diabetes and AIDS mortality, low birth
weight, and emergency room visits attributable to childhood asthma.^2

Approximately 31 percent of adults in the city of St. Louis are obese.^2
Additionally, St. Louis is one of the top 10 most challenging places to live
with asthma^3—11.4 percent of children in the city have been diagnosed with
the disease.^2

Still, these problems continue in spite of the leading academic, medical
institutions, community-based non-profit and city efforts that have
demonstrated success.

The town hall meeting, moderated by John Donvan, correspondent for ABC News,
will challenge conventional thinking about what it means to be a healthy
community and get participants to think more broadly about issues affecting
their city. The meeting will feature innovative technology to integrate
attendees into the on-stage conversation on community health to have a
solutions-oriented conversation based on feedback from attendees
representative of the broader St. Louis community.

Each group from the audience will use iPads powered by MtgWorks^TM, an app
that allows for the rapid collection of responses and the real-time synthesis
of key themes, which will then be explored by the guest panel in a large
discussion.

Additional information about "A Conversation on Community Health," hosted by
The Atlantic - The St. Louis town hall will be available via live stream from
3 – 5:30 p.m. ET on Wednesday, December 12 at http://events.theatlantic.com.

Over the course of the three city program, The Atlantic will be exploring the
many facets of community health through an ongoing special report available at
http://theatlantic.com/special-report/health-nation.

Join the conversation on Twitter @GSKUS or @Atlantic_Live, #HealthyCommunity.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and
healthcare companies – is committed to improving the quality of human life by
enabling people to do more, feel better and live longer. For further
information go to us.gsk.com, follow us on twitter.com/GSKUS or visit our blog
(www.morethanmedicine.us.gsk.com/blog/).

^1Kulkarni et al. Population Health Metrics 2011, 9:16
http://www.pophealthmetrics.com/content/9/1/16

^2St. Louis Regional Health Commission. Decade Review of Health Status for St.
Louis City and County 2000-2010. http://www.stlrhc.org/. Accessed Dec. 6,
2012.

^3Asthma and Allergy Foundation of America. Asthma Capitals 2012.
http://www.asthmacapitals.com. Accessed Nov. 28, 2012.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation
Reform Act of 1995, GSK cautions investors that any forward-looking statements
or projections made by GSK, including those made in this announcement, are
subject to risks and uncertainties that may cause actual results to differ
materially from those projected. Factors that may affect GSK' s operations are
described under 'Risk Factors' in the 'Business Review' in the company' s
Annual Report on Form 20-F for 2011.

Registered in England & Wales:

No. 3888792
Registered Office:

980 Great West Road

Brentford, Middlesex

TW8 9GS

SOURCE GlaxoSmithKline plc

Website: http://www.gsk.com
Contact: Washington, DC: Sarah Alspach, +1-202-715-1048; or Philadelphia:
Jennifer Armstrong +1-215-751-5664, for GlaxoSmithKline plc